Directors' dealings

Archive 2014

Directors' Dealings

Pursuant to § 15a German Securities Trading Act (WpHG), members of the management board and supervisory board of Biotest AG, as well as any other persons performing executive functions with Biotest AG, are obliged to notify Biotest AG and the German Federal Financial Supervisory Authority (BaFin) of own transactions in Biotest shares, or financial instruments based on them. The notification duty also applies to individuals and legal entities closely associated with such persons.

Biotest AG will disclose details of any such transactions on this website without undue delay and will transmit to the German Federal Financial Supervisory Authority evidence of such disclosure.

Directors' Dealings in accordance with §15a WpHG
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Aug 12, 2014 Purchase Stuttgart 70.10 EUR 400 28040
 Details of person:
Name/Company Reason Position
Markus Prof. Dr. Rothenburger
Biotest AG
Person performing managerial responsibilities Division Head of Medical/Regulatory Affairs
 Basic data:
Description of financial instrument: Preference Shares
ISIN DE0005227235
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
May 19, 2014 Purchase Stuttgart 84.56 EUR 105 8878.80
 Details of person:
Name/Company Reason Position
Christina Dr. Erb
Biotest AG
Person performing managerial responsibilities Vice President Project Management Office
 Basic data:
Description of financial instrument: Preference Shares
ISIN DE0005227235
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
May 08, 2014 Purchase Stuttgart 85.79 EUR 250 21447.50
 Details of person:
Name/Company Reason Position
Markus Prof. Dr. Rothenburger
Biotest AG
Person performing managerial responsibilities Division Head of Medical/Regulatory Affairs
 Basic data:
Description of financial instrument: Preference Shares
ISIN DE0005227235
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
 

 
 Transaction:
Date Type of transaction Place Price per share Currency No of items Total amount traded
Mar 27, 2014 Sale außerbörslich 92.0004 EUR 3500 322001.40
 Details of person:
Name/Company Reason Relationship
OGEL GmbH Legal person, company or institution closely associated To a person performing managerial responsibilities
 Basic data:
Description of financial instrument: Ordinary Shares
ISIN DE0005227201
Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland